Evidence mapPaperPMID 42053750Full record

ArticleThe Journal of the Egyptian Public Health Association2026

Psychometric evaluation of the Arabic brief forms of the diabetes distress scale in Egyptian patients with type II diabetes.

Hazem A Sayed Ahmed, Samaa I Taha, Rehab A Mohamed, Mahmoud A Moussa, Amira E Elfouly

Abstract read
In one paragraph

Article in The Journal of the Egyptian Public Health Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hazem A Sayed Ahmed *Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Hazem-ahmed@med.suez.edu.eg.ORCID http://orcid.org/0000-0002-4922-8706
Samaa I Taha *Department of Family Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Rehab A MohamedDepartment of Family Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Mahmoud A MoussaDepartment of Psychology, Faculty of Education, Suez Canal University, Ismailia, Egypt.
Amira E ElfoulyDepartment of Family Medicine, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes distress is highly prevalent among patients with type 2 diabetes mellitus (T2DM), and is consistently associated with poor self-care, medication nonadherence, and suboptimal glycemic control, leading to worse outcomes and reduced quality of life. Despite its clinical significance, routine screening is often overlooked in primary care and family medicine settings due to limited time and resources. Brief tools, such as the 2-item (DDS-2) and 4-item (DDS-4) Diabetes Distress Scales, offer practical alternatives to longer measures; however, validated Arabic versions are lacking. Given the high burden of T2DM in the Middle East and North Africa, culturally adapted and reliable screening instruments are necessary. This study evaluated the psychometric properties of the Arabic DDS-2 and DDS-4 among Egyptian patients with T2DM.

methodsA cross-sectional study was conducted with 366 participants recruited from five urban family medicine settings in Port Said, Egypt. Internal consistency was evaluated using Cronbach’s α, and confirmatory factor analysis (CFA) was used to assess the one-factor structure of the Arabic DDS-4. Concurrent, convergent, and predictive criterion validity were assessed by examining correlations between the Arabic DDS-2 and DDS-4 and the 17-item Diabetes Distress Scale (DDS-17), Patient Health Questionnaire-9 (PHQ-9), General Medication Adherence Scale (GMAS), and glycated hemoglobin (HbA1c). Known-group validity was assessed through associations with sociodemographic and clinical characteristics. Criterion validity was evaluated using receiver operating characteristic (ROC) curves, with high diabetes distress defined by the DDS-17 cutoff (≥ 3).

resultsThe Arabic DDS-2 and DDS-4 demonstrated strong internal consistency, with Cronbach’s alpha values of 0.728 and 0.904, respectively. CFA confirmed a one-factor structure for the Arabic DDS-4. The Arabic DDS-2 and DDS-4 showed very strong correlations with the DDS-17 (r = 0.910–0.953, p < 0.001), supporting strong concurrent validity. Both scales demonstrated moderate positive correlations with depressive symptoms (r ≈ 0.53–0.55, p < 0.001) and weak negative correlations with medication adherence (r ≈ − 0.31 to − 0.33, p < 0.001), indicating good convergent validity. Their weak correlations with HbA1c (r ≈ 0.19–0.21, p < 0.001) provided evidence of fair predictive validity. Known-group validity was confirmed by higher distress scores among patients with lower education, physical inactivity, failure to achieve glycemic targets, insulin use, complications, comorbidities, depressive symptoms, and poor medication adherence (all p < 0.05). The area under the curve (AUC) was higher for the DDS-4 (0.958) than for the DDS-2 (0.846), indicating stronger discriminative ability. The DDS-2 achieved excellent specificity (99.6%) and positive predictive value (98.6%), whereas the DDS-4 showed superior sensitivity (95.9%) and negative predictive value (98.9%).

conclusionThe Arabic DDS-2 and DDS-4 are reliable and valid instruments for screening diabetes distress in Arabic-speaking patients with T2DM. Their brevity makes them particularly useful in busy clinical settings, while their psychometric strength supports application in diverse healthcare contexts and research.

Indexed as

DDS-2DDS-4Diabetes distressFamily medicine settingsPsychometric evaluationType 2 diabetes mellitus

Identifiers

PMID42053750
PMCPMC13129166

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.